School of Biological Sciences, University of Southampton, Southampton SO17 1BJ, UK; Centre for Cancer Immunology, School of Cancer Sciences, University of Southampton Faculty of Medicine, Southampton SO16 6YD, UK.
School of Biological Sciences, University of Southampton, Southampton SO17 1BJ, UK.
Biochim Biophys Acta Gen Subj. 2023 Nov;1867(11):130448. doi: 10.1016/j.bbagen.2023.130448. Epub 2023 Aug 29.
Antibodies can mediate immune recruitment or clearance of immune complexes through the interaction of their Fc domain with cellular Fc receptors. Clustering of antibodies is a key step in generating sufficient avidity for efficacious receptor recognition. However, Fc receptors may be saturated with prevailing, endogenous serum immunoglobulin and this raises the threshold by which cellular receptors can be productively engaged. Here, we review the factors controlling serum IgG levels in both healthy and disease states, and discuss how the presence of endogenous IgG is encoded into the functional activation thresholds for low- and high-affinity Fc receptors. We discuss the circumstances where antibody engineering can help overcome these physiological limitations of therapeutic antibodies. Finally, we discuss how the pharmacological control of Fc receptor saturation by endogenous IgG is emerging as a feasible mechanism for the enhancement of antibody therapeutics.
抗体可以通过其 Fc 结构域与细胞 Fc 受体的相互作用来介导免疫细胞募集或清除免疫复合物。抗体的聚集是产生有效受体识别所需足够亲和力的关键步骤。然而,Fc 受体可能会被流行的内源性血清免疫球蛋白饱和,从而提高了细胞受体能够有效参与的阈值。在这里,我们综述了控制健康和疾病状态下血清 IgG 水平的因素,并讨论了内源性 IgG 如何编码为低亲和性和高亲和性 Fc 受体的功能激活阈值。我们讨论了抗体工程如何帮助克服治疗性抗体的这些生理限制的情况。最后,我们讨论了内源性 IgG 对 Fc 受体饱和的药理学控制如何作为增强抗体治疗药物的可行机制。